Gao Qi, Cekuc Mehmet Sertac, Ergul Yasemin Sude, Pius Alexa K, Shinohara Issei, Murayama Masatoshi, Susuki Yosuke, Ma Chao, Morita Mayu, Chow Simon Kwoon-Ho, Goodman Stuart B
Department of Orthopaedic Surgery, Stanford University, Stanford, CA 94304, USA.
Bioengineering (Basel). 2024 Nov 27;11(12):1199. doi: 10.3390/bioengineering11121199.
Mesenchymal stem cells (MSCs) play an important role in regenerative medicine and drug discovery due to their multipotential differentiation capabilities and immunomodulatory effects. Compared with traditional 2D cultures of MSCs, 3D cultures of MSCs have emerged as an effective approach to enhance cell viability, proliferation, and functionality, and provide a more relevant physiological environment. Here, we review the therapeutic potential of 3D-cultured MSCs, highlighting their roles in tissue regeneration and repair and drug screening. We further summarize successful cases that apply 3D MSCs in modeling disease states, enabling the identification of novel therapeutic strategies. Despite these promising applications, we discuss challenges that remain in the clinical translation of 3D MSC technologies, including stability, cell heterogeneity, and regulatory issues. We conclude by addressing these obstacles and emphasizing the need for further research to fully exploit the potential of 3D MSCs in clinical practice.
间充质干细胞(MSCs)因其多能分化能力和免疫调节作用,在再生医学和药物研发中发挥着重要作用。与传统的间充质干细胞二维培养相比,间充质干细胞的三维培养已成为一种增强细胞活力、增殖和功能的有效方法,并提供了更相关的生理环境。在此,我们综述三维培养的间充质干细胞的治疗潜力,强调它们在组织再生和修复以及药物筛选中的作用。我们进一步总结了将三维间充质干细胞应用于疾病状态建模的成功案例,从而能够识别新的治疗策略。尽管有这些有前景的应用,我们讨论了三维间充质干细胞技术临床转化中仍然存在的挑战,包括稳定性、细胞异质性和监管问题。我们通过解决这些障碍并强调需要进一步研究以充分利用三维间充质干细胞在临床实践中的潜力来得出结论。